These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 18874033)

  • 21. Zika virus infection, associated microcephaly, and low yellow fever vaccination coverage in Brazil: is there any causal link?
    De Góes Cavalcanti LP; Tauil PL; Alencar CH; Oliveira W; Teixeira MM; Heukelbach J
    J Infect Dev Ctries; 2016 Jun; 10(6):563-6. PubMed ID: 27367003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fractional-dose yellow fever vaccination: how much more can we do with less?
    Visser LG
    Curr Opin Infect Dis; 2019 Oct; 32(5):390-393. PubMed ID: 31335440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Vaccination against yellow fever].
    KOUWENAAR W
    Ned Tijdschr Geneeskd; 1952 Dec; 96(50):3146-9. PubMed ID: 13046556
    [No Abstract]   [Full Text] [Related]  

  • 24. Yellow fever vaccination for Chilean tourists visiting Brazil. Practical considerations.
    Weitzel T; Perret C; Valdivieso F; Abarca K; Vial P
    Rev Chilena Infectol; 2018; 35(5):587-590. PubMed ID: 30725008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Assessment of vaccination coverage among travelers to areas where yellow fever is endemic (Senegal)].
    Rapp C; Fall KB; Tall A; Michel R; Royon P; de Gentile L; Leroy JP; Caumes E; Bouchaud O
    Med Sante Trop; 2013 May; 23(2):236. PubMed ID: 24001654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recent immunization against measles does not interfere with the sero-response to yellow fever vaccine.
    Stefano I; Sato HK; Pannuti CS; Omoto TM; Mann G; Freire MS; Yamamura AM; Vasconcelos PF; Oselka GW; Weckx LW; Salgado MF; Noale LF; Souza VA
    Vaccine; 1999 Mar; 17(9-10):1042-6. PubMed ID: 10195613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Yellow fever vaccination as prophylaxis of herpes labialis].
    Møller A; Andersen PL; Korsager B; Black FT
    Ugeskr Laeger; 1997 Apr; 159(15):2228-9. PubMed ID: 9148548
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Vaccination against yellow fever].
    DE ANDRADE FILHO O
    J Pediatr (Rio J); 1953; 18(3-4):73-80. PubMed ID: 13069181
    [No Abstract]   [Full Text] [Related]  

  • 29. TWO EPISODES OF DENGUE FEVER, CAUSED BY TYPES 4 AND 1 VIRUSES, IN AN INDIVIDUAL PREVIOUSLY IMMUNIZED AGAINST YELLOW FEVER.
    CAREY DE; MYERS RM; RODRIGUES FM
    Am J Trop Med Hyg; 1965 May; 14():448-50. PubMed ID: 14292751
    [No Abstract]   [Full Text] [Related]  

  • 30. Duration of post-vaccination humoral immunity against yellow fever in children.
    de Noronha TG; de Lourdes de Sousa Maia M; Geraldo Leite Ribeiro J; Campos Lemos JA; Maria Barbosa de Lima S; Martins-Filho OA; Campi-Azevedo AC; da Silva Freire M; de Menezes Martins R; Bastos Camacho LA;
    Vaccine; 2019 Nov; 37(48):7147-7154. PubMed ID: 31590934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is the absence or intermittent YF vaccination the major contributor to its persistent outbreaks in eastern Africa?
    Baba MM; Ikusemoran M
    Biochem Biophys Res Commun; 2017 Oct; 492(4):548-557. PubMed ID: 28109882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vaccination against yellow fever and cholera.
    DICK GW
    Practitioner; 1959 Sep; 183():305-12. PubMed ID: 13816575
    [No Abstract]   [Full Text] [Related]  

  • 33. The preparation of 17D virus yellow fever vaccine in mouse brain.
    CANNON DA; DEWHURST F
    Ann Trop Med Parasitol; 1955 Jun; 49(2):174-82. PubMed ID: 13239080
    [No Abstract]   [Full Text] [Related]  

  • 34. CIRCULATING VIRUS, INTERFERON AND ANTIBODY AFTER VACCINATION WITH THE 17-D STRAIN OF YELLOW-FEVER VIRUS.
    WHEELOCK EF; SIBLEY WA
    N Engl J Med; 1965 Jul; 273():194-8. PubMed ID: 14306335
    [No Abstract]   [Full Text] [Related]  

  • 35. Suspected YF-AND after yellow fever vaccination in Finland.
    Jääskeläinen AJ; Huhtamo E; Kivioja R; Domingo C; Vene S; Kallio-Kokko H; Niedrig M; Tienari PJ; Vapalahti O
    J Clin Virol; 2014 Nov; 61(3):444-7. PubMed ID: 25223921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccination against yellow fever in French Guiana: The impact of educational level, negative beliefs and attitude towards vaccination.
    Koïvogui A; Carbunar A; Imounga LM; Laruade C; Laube S
    Travel Med Infect Dis; 2017; 15():37-44. PubMed ID: 27789244
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccination by scarification with 17D yellow fever vaccine prepared at Yaba, Lagos, Nigeria.
    CANNON DA; DEWHURST F
    Ann Trop Med Parasitol; 1953 Dec; 47(4):381-93. PubMed ID: 13125271
    [No Abstract]   [Full Text] [Related]  

  • 38. The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever.
    Jentes ES; Poumerol G; Gershman MD; Hill DR; Lemarchand J; Lewis RF; Staples JE; Tomori O; Wilder-Smith A; Monath TP;
    Lancet Infect Dis; 2011 Aug; 11(8):622-32. PubMed ID: 21798462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Anti-NMDAR encephalitis as a serious adverse event probably related to yellow fever vaccination].
    Hozáková L; Slonková J; Blahutová Š
    Klin Mikrobiol Infekc Lek; 2018 Mar; 24(1):17-19. PubMed ID: 30016535
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A comparison of the serological effects of classical cholera vaccine and of purified fraction vaccine, with or without simultaneous yellow fever vaccine (author's transl)].
    Gateff C; Dodin A; Wiart J
    Ann Microbiol (Paris); 1975; 126(2):231-46. PubMed ID: 1098542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.